COL1A1 and osteogenesis imperfecta: However, in another OI model, Col1a1 Jrt/+ mice, which differ from the previous ones by a clear propensity to fractures, the administration of the same anti-TGF-β1 D11 antibody had no impact on bone mass, nor on the quality of the bone matrix [352].